MODULADORES SELETIVOS DA PROGESTERONA NO TRATAMENTO DA HEMORRAGIA UTERINA

• 收藏
• 分享

专利权人:

PREGLEM S.A.

发明人:

BARTHOLOMEUS C. J. M. FAUSER,ERNEST LOUMAYE

申请号：

PT08737471

公开号：

PT2148681E

申请日:

2008.04.18

申请国别(地区):

PT

年份:

2016

代理人:

摘要：

Progesterone antagonists and SPRM are useful to prepare a medication for the treatment or the prophylaxis of excessive uterine bleeding in women with spontaneous or iatrogenic coagulation disorders such as thrombopenia, coagulation factor deficiency or anti-coagulant therapy. Treatment will last from 1 day to 180 days.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/